| Literature DB >> 21716622 |
Abstract
BACKGROUND: The exploitation and utilization of vast varieties of herbal extracts may serve as alternative measures to deter aggregation of deoxygenated sickle cell hemoglobin (deoxyHbS) molecules.Entities:
Keywords: A. occidentale; DeoxyHbS; P. guajava; Polymerization; T. catappa
Year: 2011 PMID: 21716622 PMCID: PMC3113351 DOI: 10.4103/0973-1296.80670
Source DB: PubMed Journal: Pharmacogn Mag ISSN: 0973-1296 Impact factor: 1.085
Figure 1Change in absorbance of erythrocyte haemolysate of HbSS genotype in the presence of aqueous extract of A. occidentale
Figure 3Change in absorbance of erythrocyte haemolysate of HbSS genotype in the presence of aqueous extract of T. catappa
Figure 2Change in absorbance of erythrocyte haemolysate of HbSS genotype in the presence of aqueous extract of P. guajava
Comparative levels of polymerization of deoxyHbS (t = 180th s) in the presence of aqueous extracts of Anacardium occidentale, Psidium guajava, and Terminalia catappa
| Time (s) | Polymerization (%) | ||||||
|---|---|---|---|---|---|---|---|
| 0 | 30 | 60 | 90 | 120 | 150 | 180 | |
| Control (n = 9) | 0.00 ± 0.00 | 93.53 ± 1.06 | 100.00 ± 1.14 | 101.96 ± 1.13 | 101.96 ± 2.14 | 101.37 ± 1.02 | 100.00 ± 0.65 |
| [ | |||||||
| 200 mg% | 0.00 ± 0.00 | 62.16 ± 1.03 | 78.43 ± 1.02 | 86.86 ± 1.13 | 90.78 ± 0.95 | 97.45 ± 0.99 | 100.00 ± 1.33 |
| 400 mg% | 0.00 ± 0.00 | 83.73 ± 0.97 | 101.96 ± 1.00 | 110.39 ± 0.95 | 119.65 ± 1.07 | 123.53 ± 0.56 | 126.86 ± 1.78 |
| 600 mg% | 0.00 ± 0.00 | 50.98 ± 1.06 | 74.51 ± 0.98 | 79.98 ± 0.99 | 82.94 ± 0.56 | 84.90 ± 1.22 | 86.86 ± 1.11 |
| 800 mg% | 0.00 ± 0.00 | 61.37 ± 0.96 | 70.59 ± 1.00 | 74.51 ± 1.66 | 78.43 ± 1.88 | 80.98 ± 0.96 | 83.73 ± 1.33 |
| [ | |||||||
| 200 mg% | 0.00 ± 0.00 | 21.37 ± 1.34 | 20.59 ± 2.32 | 20.59 ± 2.11 | 20.61 ± 1.88 | 20.62 ± 2.00 | 20.63 ± 2.22 |
| 400 mg% | 0.00 ± 0.00 | 22.55 ± 0.77 | 23.92 ± 0.99 | 22.55 ± 1.23 | 22.56 ± 1.34 | 22.57 ± 1.77 | 22.55 ± 1.00 |
| 600 mg% | 0.00 ± 0.00 | 16.27 ± 0.88 | 19.02 ± 1.54 | 20.98 ± 1.43 | 21.57 ± 0.97 | 21.76 ± 0.98 | 22.16 ± 1.34 |
| 800 mg% | 0.00 ± 0.00 | 14.31 ± 2.11 | 18.24 ± 1.78 | 20.20 ± 1.56 | 22.16 ± 2.00 | 23.53 ± 1.32 | 23.53 ± 1.43 |
| [ | |||||||
| 200 mg% | 0.00 ± 0.00 | 75.10 ± 1.34 | 79.02 ± 2.34 | 81.76 ± 2.43 | 82.35 ± 1.09 | 84.31 ± 1.22 | 84.31 ± 1.89 |
| 400 mg% | 0.00 ± 0.00 | 83.73 ± 1.43 | 92.75 ± 1.54 | 94.41 ± 1.43 | 101.96 ± 1.32 | 103.92 ± 0.97 | 105.88 ± 0.76 |
| 600 mg% | 0.00 ± 0.00 | 62.75 ± 1.90 | 71.18 ± 1.43 | 75.10 ± 1.09 | 80.39 ± 0.98 | 82.94 ± 0.89 | 84.31 ± 1.00 |
| 800 mg% | 0.00 ± 0.00 | 92.75 ± 1.23 | 104.51 ± 0.85 | 109.22 ± 1.33 | 114.31 ± 1.11 | 117.64 ± 1.37 | 119.61 ± 1.20 |
The results are means (X) ± SD of nine (n = 9) determinations
Relative levels of inhibition/activation of deoxyHbS polymerization (t = 30 s intervals) in the presence of aqueous extracts of Anacardium occidentale, Psidium guajava, and Terminalia catappa
| Time (s) | Polymerization inhibition/activation (%) | |||||
|---|---|---|---|---|---|---|
| 30 | 60 | 90 | 120 | 150 | 180 | |
| [ | ||||||
| 200 mg% | 33.96 ± 1.54 | 23.08 ± 1.09 | 16.42 ± 0.98 | 12.64 ± 1.34 | 4.42 ± 1.11 | 1.92 ± 1.87 |
| 400 mg% | 11.04 ± 1.43 | 0.01 ± 0.11 | 6.23 | 14.53 | 21.15 | 24.42 |
| 600 mg% | 45.83 ± 1.34 | 26.92 ± 1.76 | 23.21 ± 1.09 | 20.19 ± 1.12 | 16.73 ± 1.66 | 14.81 ± 2.09 |
| 800 mg% | 34.79 ± 1.32 | 30.77 ± 0.99 | 28.30 ± 0.67 | 24.53 ± 0.89 | 20.58 ± 1.67 | 17.88 ± 1.77 |
| [ | ||||||
| 200 mg% | 77.29 ± 1.01 | 79.81 ± 1.34 | 80.19 ± 1.78 | 80.17 ± 1.99 | 79.78 ± 1.00 | 79.77 ± 1.37 |
| 400 mg% | 76.04 ± 1.43 | 76.54 ± 1.32 | 78.30 ± 1.11 | 78.29 ± 1.09 | 77.86 ± 1.28 | 77.88 ± 0.99 |
| 600 mg% | 82.71 ± 1.00 | 81.35 ± 1.95 | 79.81 ± 1.45 | 79.25 ± 0.90 | 78.65 ± 0.69 | 78.27 ± 1.56 |
| 800 mg% | 84.79 ± 1.99 | 82.12 ± 1.98 | 80.57 ± 0.67 | 78.68 ± 1.07 | 76.92 ± 0.97 | 76.92 ± 1.43 |
| [ | ||||||
| 200 mg% | 20.21 ± 1.77 | 22.50 ± 1.27 | 21.32 ± 1.34 | 20.75 ± 2.04 | 17.31 ± 1.09 | 17.31 ± 1.04 |
| 400 mg% | 11.04 ± 1.54 | 9.04 ± 1.00 | 4.34 ± 1.71 | 1.89 ± 1.90 | 1.89 | 3.85 ± 1.43 |
| 600 mg% | 37.47 ± 1.48 | 30.19 ± 1.00 | 27.74 ± 1.07 | 22.64 ± 1.45 | 18.65 ± 1.04 | 17.31 ± 1.07 |
| 800 mg% | 1.46 ± 1.66 | 2.50 | 5.09 | 10.00 | 15.38 | 17.31 |
The results are means (X) ± S.D of nine (n = 9) determinations
Activation (%)